Morphic Holding, Inc. logo

Morphic Holding, Inc.

NASDAQ:MORF

Overview | Financials
Company Name Morphic Holding, Inc.
Symbol MORF
Currency USD
Price 56.99
Market Cap 2,862,305,653
Dividend Yield 0%
52-week-range 19.345 - 57
Industry Biotechnology
Sector Healthcare
CEO Dr. Praveen P. Tipirneni M.D.
Website https://www.morphictx.com

An error occurred while fetching data.

About Morphic Holding, Inc.

Morphic Holding, Inc., a biopharmaceutical company, discovers and develops oral small-molecule integrin therapeutics for the treatment of autoimmune, cardiovascular, metabolic diseases, as well as fibrosis and cancer. Its lead product candidates are MORF-057, an a4ß7-specific integrin inhibitor affecting inflammation that is in Phase 1 clinical trial for the treatment of

Related Stocks

National Research Corporation logo

National Research Corporation

NRC

17.94 USD

REGENXBIO Inc. logo

REGENXBIO Inc.

RGNX

7.87 USD

Keros Therapeutics, Inc. logo

Keros Therapeutics, Inc.

KROS

16.81 USD

Syndax Pharmaceuticals, Inc. logo

Syndax Pharmaceuticals, Inc.

SNDX

12.925 USD

Treace Medical Concepts, Inc. logo

Treace Medical Concepts, Inc.

TMCI

7.08 USD

Cerus Corporation logo

Cerus Corporation

CERS

1.66 USD

Mirum Pharmaceuticals, Inc. logo

Mirum Pharmaceuticals, Inc.

MIRM

42.03 USD

Sana Biotechnology, Inc. logo

Sana Biotechnology, Inc.

SANA

1.7 USD

Procaps Group S.A. logo

Procaps Group S.A.

PROC

2.47 USD

Financials

Numbers are in millions USD

Numbers are in millions USD